Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 2692111

Constructing a cut-off point for a quantitative diagnostic test.

H Schäfer
View original source ↗Export metadata ↓

Abstract

This paper is concerned with the problem of constructing a suitable cut-off point for a quantitative diagnostic test from a sample of diseased and non-diseased individuals, when the specificity and/or sensitivity required for the resulting diagnostic classification rule are specified. Statistical procedures are discussed which yield an explicit cut-off point, together with the necessary confidence limits on the true specificity and sensitivity of the test operating at this point (by contrast to confidence limits referring to an unknown optimal choice of the cut-off point). Sample size formulae are derived, showing a relative efficiency of up to 1.5 for a new procedure introduced in this paper over the usual procedure based on tolerance limits.

Explore related subjects

BiopsyBone MarrowDiagnosisHumansL-Lactate DehydrogenaseNormal DistributionSensitivity and SpecificityJournal ArticleResearch Support, Non-U.S. Gov't

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H Schäfer. 1989. Constructing a cut-off point for a quantitative diagnostic test.. https://doi.org/10.1002/sim.4780081110

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Non-radical diagnostic biopsies do not negatively influence melanoma patient survival.

BACKGROUND: In fair-skinned Caucasian populations both the incidence and mortality rates of cutaneous melanoma have been increasing over the past decades. With adjuvant therapies still being under investigation, early detection is the only way to improve melanoma patient survival. The influence of incisional biopsies on melanoma patient survival has been discussed for many years. This study investigates both the influence of diagnostic biopsy type and the presence of residual tumor cells in the re-excision specimen on disease free and overall survival. METHODS: After (partial) removal of a pigmented skin lesion 471 patients were diagnosed with stage I/II melanoma and underwent re-excision and a sentinel node biopsy. All patients were followed prospectively, mean follow up >5 years. Patients were divided according to their diagnostic biopsy type (wide excision biopsy, narrow excision biopsy, excision biopsy with positive margins and incisional biopsy) and the presence of residual tumor cells in their re-excision specimen. Survival analysis was done using Cox's proportional hazard model adjusted for eight important confounders of melanoma patient survival. RESULTS: The diagnostic biopsy was wide in 279 patients, narrow in 109 patients, 52 patients underwent an excision biopsy with positive margins and 31 patients an incisional biopsy. In 41 patients residual tumor cells were present in the re-excision specimen. Both the diagnostic biopsy type and the presence of tumor cells in the re-excision specimen did not influence disease free and overall survival of melanoma patients. CONCLUSIONS: Non-radical diagnostic biopsies do not negatively influence melanoma patient survival.

Biopsy↗